Equities research analysts expect Trupanion Inc (NYSE:TRUP) to report ($0.05) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Trupanion’s earnings, with estimates ranging from ($0.05) to ($0.04). Trupanion posted earnings of ($0.06) per share in the same quarter last year, which would suggest a positive year over year growth rate of 16.7%. The firm is expected to announce its next earnings report on Tuesday, November 7th.

According to Zacks, analysts expect that Trupanion will report full year earnings of ($0.09) per share for the current fiscal year, with EPS estimates ranging from ($0.09) to ($0.08). For the next financial year, analysts anticipate that the firm will report earnings of $0.01 per share, with EPS estimates ranging from ($0.02) to $0.07. Zacks’ earnings per share averages are an average based on a survey of sell-side research firms that cover Trupanion.

Trupanion (NYSE:TRUP) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.01. Trupanion had a net margin of 0.71% and a return on equity of 3.57%. The company had revenue of $58.30 million during the quarter, compared to analysts’ expectations of $57.58 million. During the same quarter in the previous year, the company earned ($0.03) earnings per share. The firm’s revenue for the quarter was up 27.3% on a year-over-year basis.

A number of research firms have recently weighed in on TRUP. Cowen and Company reaffirmed an “outperform” rating and set a $28.00 price target (up from $19.00) on shares of Trupanion in a research note on Wednesday, August 2nd. BidaskClub upgraded shares of Trupanion from a “sell” rating to a “hold” rating in a report on Friday, September 22nd. Royal Bank Of Canada raised their price objective on shares of Trupanion from $19.00 to $26.00 and gave the company an “outperform” rating in a research note on Wednesday, August 2nd. Stifel Nicolaus reiterated a “buy” rating and issued a $24.00 price objective (up previously from $18.00) on shares of Trupanion in a research note on Wednesday, August 2nd. Finally, Northland Securities set a $23.00 price objective on shares of Trupanion and gave the stock a “buy” rating in a report on Thursday, July 6th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Trupanion currently has a consensus rating of “Buy” and an average price target of $24.50.

Shares of Trupanion (TRUP) traded up 2.88% during midday trading on Tuesday, reaching $26.83. 216,533 shares of the company traded hands. Trupanion has a 1-year low of $13.71 and a 1-year high of $27.00. The stock’s 50-day moving average is $23.05 and its 200-day moving average is $20.05. The stock’s market capitalization is $804.77 million.

In other Trupanion news, COO Ian Moffat sold 8,552 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $23.20, for a total value of $198,406.40. Following the sale, the chief operating officer now owns 8,552 shares of the company’s stock, valued at $198,406.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Darryl Rawlings sold 3,500 shares of the company’s stock in a transaction dated Wednesday, September 20th. The shares were sold at an average price of $23.75, for a total transaction of $83,125.00. Following the completion of the sale, the insider now directly owns 1,446,005 shares in the company, valued at approximately $34,342,618.75. The disclosure for this sale can be found here. Insiders sold 54,052 shares of company stock worth $1,229,454 in the last three months.

Hedge funds have recently added to or reduced their stakes in the company. Capital World Investors increased its stake in shares of Trupanion by 1.7% during the 2nd quarter. Capital World Investors now owns 2,380,800 shares of the financial services provider’s stock worth $53,282,000 after purchasing an additional 40,500 shares in the last quarter. Nine Ten Capital Management LLC raised its position in shares of Trupanion by 53.4% during the 1st quarter. Nine Ten Capital Management LLC now owns 1,112,380 shares of the financial services provider’s stock worth $15,818,000 after purchasing an additional 387,320 shares during the last quarter. Baillie Gifford & Co. lifted its stake in Trupanion by 12.3% in the 2nd quarter. Baillie Gifford & Co. now owns 982,373 shares of the financial services provider’s stock valued at $21,985,000 after buying an additional 107,373 shares in the last quarter. Wellington Management Group LLP lifted its stake in Trupanion by 71.8% in the 1st quarter. Wellington Management Group LLP now owns 929,226 shares of the financial services provider’s stock valued at $13,213,000 after buying an additional 388,226 shares in the last quarter. Finally, Vanguard Group Inc. lifted its stake in Trupanion by 16.6% in the 2nd quarter. Vanguard Group Inc. now owns 758,594 shares of the financial services provider’s stock valued at $16,977,000 after buying an additional 108,135 shares in the last quarter.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/03/zacks-brokerages-anticipate-trupanion-inc-trup-will-announce-earnings-of-0-05-per-share.html.

About Trupanion

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related companies with MarketBeat.com's FREE daily email newsletter.